They deserved it – Pow! Right on the Kisser! The Pharmaceutical and Biotechnology industry takes another blow. As reported by The New York Times “Judge Invalidates Human Gene Patent“ the Judge struck down Myriad Genetics patents on two breast cancer genes – BRCA1 and BRCA2, threatening billions in industry revenues. Don’t get me wrong, I’m all… more »
Who are the global researchers leading the pack in research for Diabetes Type II? It may not be the people you expected!
After 200 peer review papers and countless other readings, I can safely say I’ve scratched the surface of social network analysis. For a 40-year-old science, it can still feel like a new challenge daily, and I’m often asked where to start in terms of learning the ropes.
Some pharmaceutical and biotech companies just don’t know how to network. It’s time they learn. Networking for our next job. It’s a familiar task for many of us. We reach out to our connections, both strong connections and our weak associations, creating if you will a radar dish. Our friends and associates listen on our… more »
When the pharmaceutical research community is huge, how do you network effectively? How do you find the right people to tap into their expertise or leverage their social capital?
Most of us are just part of some some social system and experience it firsthand. We learn who to ask for help. We learn who to avoid. But generally, we never bother to look at the whole or macro system – we are content to understand our immediate environment only.
When I started on this grand venture, I had no idea I’d be writing a blog, but three and a half years later, here I am, Philip Topham, General manager for Lnx Pharma, an explorer into social network analysis (SNA).